Insulet Corporation的股票暴涨,因为它比收入估计数要高,吸引更多的投资者。 Insulet Corporation's stock soars as it beats earnings estimates, attracting more investors.

向糖尿病患者提供胰岛素的Insulet Corporation(Insulet Corporation)在第一季度看到其份额大幅上升,Robeco和PDS Planning等投资者购买了更多的股票。 Insulet Corporation, which makes insulin delivery systems for people with diabetes, saw its shares rise sharply in the first quarter, with investors like Robeco and PDS Planning buying more stock. Insulet报告收入为每股1.02美元,殴打估计数为0.21美元,市场上限为22.03亿美元。 Insulet reported earnings of $1.02 per share, beating estimates by $0.21, and has a market cap of $22.03 billion. 分析员预测该年每股3.92美元的收入,股票价格目标是321.00美元。 Analysts predict $3.92 earnings per share for the year, with a stock price target of $321.00.